Ernest Graeme Harvey

Introduction: Ernest Graeme Harvey is a distinguished inventor based in Avon, Indiana, recognized for his significant contributions to the field of biomedical technology. With a total of four patents to his name, Harvey's innovations demonstrate his commitment to enhancing healthcare solutions, particularly in diabetes management.

Latest Patents: Among his latest inventions is a novel disposal system designed for the safe storage of used or contaminated articles, such as diagnostic biosensors. This unique disposal container system features a flat, strip-shaped design that allows users to insert contaminated articles through a specifically contoured slit. The exterior contour guides the deposit while ensuring that loose articles within the container are effectively deflected away from the slit, preventing accidental extraction. This innovation holds promise for improving safety protocols in healthcare settings.

Another significant patent is related to a container assembly created to work in tandem with a supply container, which may come in both round and non-round configurations. This invention demonstrates Harvey's focus on practical solutions for complex problems faced by healthcare professionals.

Career Highlights: Ernest Graeme Harvey is currently employed with Roche Diabetes Care, Inc., a leading company in the field of diabetes management and care. His work at Roche underscores his commitment to advancing medical technology that enhances the quality of life for people living with diabetes.

Collaborations: In the course of his career, Ernest has collaborated with several talented individuals, including his coworker Michel A Cadio. Their joint efforts contribute to the innovative environment at Roche, where they work together to develop solutions that meet the evolving needs of the healthcare industry.

Conclusion: Ernest Graeme Harvey's contributions to medical technology through his patents reflect his dedication to improving healthcare systems. His inventive spirit and collaborative approach have left a mark on the medical community, and as advancements continue, his innovations will likely play a crucial role in shaping the future of diabetes care and safety in biomedical practices.

Profile summary based on public USPTO records.